Clinical Trial Update: Melatonin Agonist on Hospitalized Patients With Confirmed or Suspected COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating a melatonin agonist for hospitalized patients with confirmed or suspected COVID-19, including those with lung injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury

Snippet

Sponsor: Associação Fundo de Incentivo à Pesquisa | Conditions: Covid19, Lung Injury | Phase 2 | Status: UNKNOWN